表紙
市場調査レポート

プレフィルドシリンジ(薬剤充填済み注射器)市場の予測

Prefilled Syringes to 2022

発行 Greystone Research Associates 商品コード 321891
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
プレフィルドシリンジ(薬剤充填済み注射器)市場の予測 Prefilled Syringes to 2022
出版日: 2015年01月01日 ページ情報: 英文
概要

注射による投薬は多くの薬剤にとって欠かすことのできないものです。医療費削減のためのマネージドケアプロバイダーによる取組みによって、慢性疾患などのための薬剤自己投与が普及し、非経口ドラッグデリバリーの使用が広がりました。プレフィルドシリンジ(薬剤充填済み注射器)の使用拡大によって安全性問題への注目が高まり、プレフィルセーフティシリンジや安全性の高いソリューションが市販されるようになっています。

当レポートでは、プレフィルドシリンジ(薬剤充填済み注射器)市場について詳細に調査し、市場の動向、需要、主な治療分野別の製品概要、2022年までの製品データと市場シェア予測、市場に参入する企業のプロファイルなどをまとめています。

エグゼクティブサマリー

プレフィルデバイス動向

装置技術の発展

  • サプライチェーン要因
  • 業界統合
  • 競合環境
  • 需要促進因子

治療市場要因

創薬と新薬開発

  • 疾患と適応
  • 患者動向
  • 投与頻度と安全性
  • マネージドケアの取組み

プレフィルドシリンジ:設計要因

薬剤の安定性と寿命

  • 材料選択問題
  • ポイントオブユースの再構築
  • 介護者の安全性
  • 針管理戦略
  • ヒューマンエンジニアリング/エルゴノミクス

プレフィルドシリンジ:商用装置

  • プレフィル治療用注射器
  • ガラス製プレフィルドシリンジ
  • プラスチック製プレフィルドシリンジ
  • 即時充填可能なシリンジ
  • 特殊プレフィルドシリンジ

市場セグメント

  • アナフィラキシー
  • 抗凝固剤
  • 自己免疫疾患
  • 救急医療
  • 肝炎
  • 造血・赤血球生成促進タンパク質
  • 代謝性疾患
  • 神経科
  • 再生医療
  • ワクチン

非APIプレフィルドシリンジセグメント

自己投与と患者の適合性

  • 法規制ガイダンスと製品認可
  • PFSエコシステムの展開

企業プロファイル

目次
Product Code: PFJ634K

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.

Highlights

  • Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments
  • Examines design factors, material selection issues, technologies and market development issues
  • Provides product data, market share, and forecasts to 2022
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

What You Will Learn

  • What drugs are supplied in prefilled syringes, what are the device specifics, and who markets them?
  • Who are the branded prefilled syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
  • What are the major factors driving prefilled syringe demand?
  • How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
  • What are the essential design factors, material selection issues, technologies and market development issues for injectable drug products?
  • What are prefilled device categories that compete with prefilled syringes and what is their market share?

Table of Contents

  • Executive Summary
  • The Prefilled Device Landscape
  • Evolving Device Technology
  • Supply Chain Factors
  • Industry Alignment
  • Competitive Landscape
  • Demand Drivers
  • Therapeutic Market Factors
  • Drug Discovery and Development
  • Diseases and Indications
  • Patient Demographics
  • Dosing Frequency and Safety
  • Managed Care Initiatives
  • Prefilled Syringes - Design Factors
  • Drug Stability and Shelf Life
  • Material Selection Issues
  • Point-of-Use Reconstitution
  • Caregiver Safety
  • Needle Configuration Strategies
  • Human Engineering/Ergonomics
  • Prefilled Syringes - Commercial Devices
  • Prefillable Therapeutic Injectables
  • Glass Prefillable Syringes
  • Plastic Prefillable Syringes
  • Ready-to-Fill Safety Syringes
  • Specialty Prefillable Syringes
  • Flush Syringes
  • Diluent Syringes
  • Imaging Agent Syringes
  • Prefilled Syringe Market Segments
  • Anaphylaxis
  • Anticoagulants
  • Autoimmune Diseases
  • Emergency Medicine
  • Hepatitis
  • Hematopoietics and Related Erythropoiesis Stimulating Proteins
  • Metabolic Diseases
  • Neurology
  • Reproductive Health
  • Vaccines
  • Non-API Prefilled Syringe Segments
  • Market Factors
  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • The Evolving PFS Ecosystem
  • Company Profiles
Back to Top